News

InteRNA Appoints Established Oncology Innovator Andrea van Elsas, PhD, to its Supervisory Board

October 12, 2021
Appointment of Andrea van Elsas as a new member of the Company's Supervisory Board.
Read more

Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series A

October 07, 2021
Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series A
Read more
Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series A

Sapreme Presents Promising New Preclinical Data at 17th Annual Meeting of Oligonucleotide Therapeutics Society

September 27, 2021
Sapreme Presents Promising New Preclinical Data at 17th Annual Meeting of Oligonucleotide Therapeutics Society
Read more
Sapreme Presents Promising New Preclinical Data at 17th Annual Meeting of Oligonucleotide Therapeutics Society

ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b

September 14, 2021
Fast Track designation for the treatment of recurrent and metastatic HPV16-positive oropharyngeal cancer to improve survival an...
Read more
ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b

ORCA Therapeutics B.V. to Start Repeat-Dosing in Phase 1/2a Study of ORCA-010 in TreatmentNaïve Prostate Cancer Patients.

September 07, 2021
ORCA Therapeutics B.V. is pleased to announce the successful completion of the single-dose escalation cohorts of the Phase I/II...
Read more
ORCA Therapeutics B.V. to Start Repeat-Dosing in Phase 1/2a Study of ORCA-010 in TreatmentNaïve Prostate Cancer Patients.

Stepping to the Exit - Publication in Nature Biotechnology

August 27, 2021
Building a business. Stepping to the exit.
Read more

A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease

August 02, 2021
Scientists from MIMETAS and Merck introduce an assay to study 3D T cell dynamics under flow and in real-time using a high-throu...
Read more
A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease

ISA, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline

July 20, 2021
Grant accelerates clinical development of immunotherapy to treat chronic hepatitis B virus infection
Read more
ISA, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline

ISA Pharmaceuticals announces successful closing of EUR 26 million funding round

July 13, 2021
The proceeds of this round will be used to advance the lead product ISA101b towards first marketing authorization as well as to...
Read more
ISA Pharmaceuticals announces successful closing of EUR 26 million funding round

MIMETAS and Roche enter into a collaboration to develop human disease models for drug development

July 06, 2021
- Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV - Upfront payment and milestone payments for MIMETAS...
Read more
MIMETAS and Roche enter into a collaboration to develop human disease models for drug development

Home > News

© 2021 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds